D‑Wave Quantum Inc. Reports Q1 2026 Results
The Canadian quantum‑computing company released its first‑quarter 2026 financial results on 12 May 2026. The filing, available through the New York Stock Exchange under the ticker QBTS, highlights a sharp decline in revenue, an increased loss per diluted share, and a substantial rise in bookings. The market’s response was mixed, with the stock trading down in pre‑market sessions while some analysts noted a temporary lift.
Financial Highlights
| Item | Q1 2026 | Q1 2025 | Comment |
|---|---|---|---|
| Net loss per diluted share | $0.05 | $0.02 | Widened relative to the same period a year earlier |
| Revenue | $2.86 million | $15.60 million | 81 % decline |
| Bookings | $12.3 million | $1.2 million | Nearly 1,000 % increase |
| GAAP EPS | -$0.05 | $0.02 | Negative earnings |
| Revenue forecast (FactSet) | — | — | Analysts had anticipated a larger loss ($0.09) |
The company reported that the revenue drop was driven by a fall in immediate sales, while the backlog of orders increased dramatically. Management emphasized that the surge in bookings reflects stronger long‑term demand for its annealing and gate‑model quantum systems.
Market Reaction
- Pre‑market trading: The share price fell by approximately 5 % at the open, reflecting investor concern over the earnings miss.
- Post‑release: Some market observers reported a short‑term rebound as the backlog surge was taken into account, but the overall sentiment remained cautious.
- Valuation: With a market capitalization of $8.36 billion, the price‑to‑earnings ratio stands at -21.8, indicative of negative earnings for the period.
Analyst Perspective
Analysts expressed mixed views. While the revenue contraction was viewed negatively, the backlog expansion was seen as a potential positive for future revenue streams. Some commentators noted that the company’s focus on commercializing quantum technology remains under scrutiny, and the recent earnings were interpreted as a step toward that goal.
Key Takeaways
- Revenue fell 81 % to $2.86 million, but bookings surged nearly 1,000 %, indicating stronger future demand.
- Net loss widened to $0.05 per diluted share, exceeding analyst expectations of a larger loss.
- The stock declined in pre‑market trading, reflecting investor discomfort with the immediate financial performance, though the backlog increase provided a counterbalancing narrative.
- The company’s valuation remains negative (P/E = -21.8) due to the current loss profile, despite a substantial market cap of $8.36 billion.
These developments underscore the volatility in the quantum‑technology sector, where short‑term revenue swings can be offset by longer‑term contractual commitments.
